PubMed:10481945 JSONTXT 8 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-106 DRI_Background denotes Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
T2 107-282 DRI_Background denotes Expression of gelsolin, an actin filament regulatory protein, in human breast ductal carcinoma in situ (DCIS) was analyzed by immunohistochemistry using a monoclonal antibody.
T3 283-297 REPLACED denotes Formalin-fixed
T4 298-315 Token_Label.OUTSIDE denotes paraffin-embedded
T5 316-522 DRI_Background denotes tissues from 59 pure DCIS specimens and 33 DCIS specimens with associated invasive components were evaluated for gelsolin reactivity and compared to eight normal breast cases and 76 invasive breast cancers.
T6 523-774 DRI_Background denotes The proportion of cases exhibiting negative/low expression of gelsolin in the epithelium was as follows -- normal, 0%; pure DCIS, 56%; DCIS associated with invasion, 58% in the DCIS component and 66% in the invasive component; invasive carcinoma, 70%.
T7 775-910 DRI_Outcome denotes These data demonstrate that down-regulation of gelsolin expression in breast epithelium frequently parallels progression to malignancy.
T8 911-1356 DRI_Unspecified denotes Testing gelsolin expression (normal vs. negative/low levels) in the DCIS lesions for associations with patient age or any of the following histopathologic parameters revealed no significant (95% probability level) correlations -- tumor size; pathologic (Van Nuys system) grade; nuclear grade; necrosis; presence of histologic calcifications; presence or type of adjacent benign lesions; architectural histologic pattern; and mammographic extent.
T9 1357-1483 DRI_Background denotes Gelsolin loss was more commonly associated with mammographic soft tissue lesions as compared to calcified lesions (P = 0.009).
T10 1484-1715 DRI_Approach denotes A positive trend of borderline significance (P = 0.06) found in the DCIS with invasion group was a correlation between down-regulated gelsolin expression in the DCIS component and size (< versus > or = 15 mm) of the invasive tumor.
T11 1716-1835 DRI_Outcome denotes In conclusion, reduced gelsolin protein is detectable in at least half of breast lesions which have progressed to DCIS.
T12 1836-2154 DRI_Approach denotes The trend between increasing gelsolin loss and malignant progression from normal epithelium to DCIS to invasive breast cancer (P < 0.0001) suggests additional investigation is needed to determine the potential of altered gelsolin expression as a marker for prognosis and for therapeutic interventions in breast cancer.